Peripherally Inserted Central Catheters Market Size & Growth Forecast 2027–2036, By Segments (Product, Lumen, End-use, Applications), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Peripherally Inserted Central Catheters Market size was more than USD 1.64 Billion in 2026 and is set to grow at 10.18% CAGR between 2027 and 2036, reaching USD 4.32 Billion by 2036. The industry revenue for 2027 is calculated at USD 1.78 Billion.
Get more details on this report
Request Free Sample ReportPeripherally Inserted Central Catheters Market Intelligence Snapshot
Regional Market Dynamics
- North America held 37.15% in 2026, supported by established hospital infrastructure, widespread intravenous therapy, clinical awareness, and demand for reliable long-term vascular access.
- Asia Pacific is the fastest-growing region, driven by expanding hospitals, rising healthcare expenditure, advanced procedures, and growing treatment needs requiring extended intravenous therapy.
Segment Momentum
- Power injected PICCs held 48.87% of the market in 2026 because they support both intravenous therapy and contrast-enhanced imaging, reducing repeated catheter placements while providing versatile vascular access across hospitals.
- Homecare settings are growing the fastest as more patients receive long-term intravenous therapies outside hospitals. Advances in home healthcare and patient monitoring are improving convenience while supporting cost-effective care delivery.
Market Expansion Drivers
- Rising prevalence of chronic diseases increasing demand for long-term intravenous access devices
- Increasing infectious disease burden driving hospital use of safe vascular access solutions
- Technological advancements improving catheter safety, durability, and insertion precision in clinical settings
Leading Market Participants
- Key players in the peripherally inserted central catheters market include Becton, Dickinson and Company (United States), Teleflex Incorporated (United States), B. Braun Melsungen AG (Germany), ICU Medical, Inc. (United States), Cardinal Health, Inc. (United States), AngioDynamics, Inc. (United States), Terumo Corporation (Japan), Cook Medical LLC (United States), Medtronic plc (Ireland)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.64 Billion
- 2027 Estimated Market Size: USD 1.78 Billion
- Projected Market Size: USD 4.32 Billion by 2036
- Growth Forecast: 10.18% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Power Injected PICC (Product) | Double (Lumen) | Hospitals (End-use) | Long-Term IV Infusion (Applications)
- Emerging Opportunity Segment: Neonatal PICC (Product) | Multiple (Lumen) | Homecare Settings (End-use) | Parenteral Nutrition (Applications)
Market Growth Drivers and Industry Trends
Rising prevalence of chronic diseases increasing demand for long-term intravenous access devices
The growing burden of chronic illnesses requiring extended medication and infusion therapies is increasing the need for reliable vascular access solutions across healthcare facilities. Rising prevalence of chronic diseases will drive the peripherally inserted central catheters market growth as patients undergoing long-term treatments rely on these devices for repeated intravenous administration while reducing the need for frequent access procedures. Healthcare providers are increasingly adopting these catheters to support treatment continuity in oncology, critical care, and chronic disease management settings.
Increasing infectious disease burden driving hospital use of safe vascular access solutions
The continued need for effective infection management is encouraging hospitals to prioritize vascular access devices designed to improve patient safety and reduce complications. Increasing infectious disease burden will propel the peripherally inserted central catheters market demand by increasing the use of secure intravenous access solutions for antibiotic therapies, prolonged treatments, and complex care protocols. These devices help clinicians manage extended treatment regimens while supporting improved patient care practices.
Technological advancements improving catheter safety, durability, and insertion precision in clinical settings
Innovation in catheter materials, placement technologies, and procedural tools is enhancing the reliability of vascular access procedures. Technological advancements improving catheter safety, durability, and insertion precision will boost the peripherally inserted central catheters market growth by enabling healthcare professionals to achieve more accurate placement and minimize procedure-related risks. Improved designs are supporting broader clinical adoption by addressing challenges associated with long-term catheter use.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of chronic diseases increasing demand for long-term intravenous access devices | 3.3% | High | North America, Europe | High | Near Term |
| Increasing infectious disease burden driving hospital use of safe vascular access solutions | 3.2% | High | Asia Pacific, Latin America | High | Near Term |
| Technological advancements improving catheter safety, durability, and insertion precision in clinical settings | 3.1% | High | North America, Europe | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
Holding the largest share of the peripherally inserted central catheters market, North America represented 37.15% of the market in 2026. The region's position is supported by well-established hospital infrastructure, widespread use of intravenous therapies, and increasing demand for reliable vascular access among patients requiring prolonged treatment. Greater adoption of minimally invasive catheterization techniques, strong clinical awareness, and established protocols for managing complex and long-term care needs are contributing to sustained utilization across healthcare facilities.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected to experience the fastest growth in the peripherally inserted central catheters market, supported by expanding hospital networks, rising healthcare expenditure, and increasing access to advanced medical procedures. Growing treatment demand for cancer, infectious diseases, and other conditions requiring extended intravenous therapy is creating opportunities for catheter adoption. Improvements in critical care and oncology infrastructure, along with greater awareness among healthcare professionals regarding vascular access management, are further strengthening regional market development.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Vascular Access InnovationThe U.S. peripherally inserted central catheters market is supported by increasing demand for long-term intravenous therapies in hospitals and outpatient settings. Healthcare providers prioritize infection prevention, ultrasound-guided placement, and improved catheter performance.
Germany 🇩🇪
Hospital Care EfficiencyGermany emphasizes peripherally inserted central catheters to improve vascular access for oncology, critical care, and long-duration treatments. Hospitals seek products that reduce complications while supporting standardized clinical procedures.
Japan 🇯🇵
Patient-Centered Infusion CareJapan adopts peripherally inserted central catheters across aging patient populations requiring prolonged intravenous treatment. Clinical priorities include minimizing insertion risks, improving patient comfort, and supporting consistent long-term vascular access.
South Korea 🇰🇷
Advanced Clinical PracticeSouth Korea expands use of peripherally inserted central catheters in tertiary hospitals and specialized treatment centers. Healthcare facilities focus on imaging-assisted placement, infection control measures, and clinician training to improve patient outcomes.
France 🇫🇷
Standardized Vascular AccessFrance promotes standardized use of peripherally inserted central catheters within oncology and chronic care services. Healthcare providers value devices that enhance treatment continuity while supporting safe catheter maintenance protocols.
Italy 🇮🇹
Long-Term Therapy SupportItaly increasingly utilizes peripherally inserted central catheters for patients requiring extended infusion therapies across hospitals and home care settings. Clinical purchasing decisions emphasize ease of placement, durability, and reduced complication risks.
Segment Leadership and Growth Trends
Peripherally Inserted Central Catheters Market Share (%), Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Power Injected PICC (Largest Segment) vs Neonatal PICC (Fastest-Growing Segment)
The power injected PICC product segment held the largest share of the peripherally inserted central catheters market, accounting for 48.87% in 2026. These catheters are widely utilized because they support both intravenous therapy and contrast-enhanced imaging procedures, allowing healthcare providers to perform multiple clinical functions through a single vascular access device. Their versatility, reduced need for repeated catheter placement, and broad use across hospital settings continue to strengthen their leading market position.
The neonatal PICC product segment is expected to witness the fastest growth. Increasing demand for specialized vascular access devices designed for premature and critically ill newborns is supporting wider adoption in neonatal care. Advances in neonatal intensive care practices, improved survival rates among preterm infants, and growing emphasis on minimizing vascular complications are expected to accelerate demand for neonatal PICCs.
Lumen Segment Analysis: Double (Largest Segment) vs Multiple (Fastest-Growing Segment)
The double lumen segment accounted for the largest share of 51.52% in 2026. Double lumen catheters are widely preferred because they enable simultaneous administration of multiple medications, fluids, or nutritional therapies while reducing the need for additional vascular access procedures. Their balance between clinical flexibility and patient comfort has made them a standard choice across diverse healthcare settings.
The multiple lumen segment is projected to record the fastest growth in the peripherally inserted central catheters market. Increasing treatment complexity, rising use of combination therapies, and growing demand for efficient critical care management are driving the adoption of catheters capable of supporting several infusion pathways simultaneously. Their ability to improve workflow efficiency and accommodate advanced treatment protocols is expected to support continued market expansion.
End-use Segment Analysis: Hospitals (Largest Segment) vs Homecare Settings (Fastest-Growing Segment)
The hospitals end-use segment captured the largest share of 41.8% in 2026. Hospitals remain the primary users of peripherally inserted central catheters due to the high volume of inpatient procedures requiring long-term intravenous therapy, chemotherapy, antimicrobial treatment, and critical care support. The availability of specialized healthcare professionals and advanced clinical infrastructure continues to reinforce the segment's dominant position.
The homecare settings end-use segment is anticipated to experience the fastest growth in the peripherally inserted central catheters market. Increasing preference for receiving long-term intravenous therapies outside hospital environments, combined with advances in home healthcare services and patient monitoring, is encouraging broader adoption. The growing focus on improving patient convenience, reducing hospital stays, and supporting cost-effective care delivery is expected to drive sustained growth in this segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Power Injected PICC, Conventional PICC, Neonatal PICC | Power Injected PICC | Neonatal PICC |
| Lumen | Single, Double, Multiple | Double | Multiple |
| End-use | Hospitals, Ambulatory Surgical Centers, Homecare Settings, Others | Hospitals | Homecare Settings |
| Applications | Chemotherapy, Long-term IV Infusion, Parenteral Nutrition, Blood Transfusion, Others | Long-Term IV Infusion | Parenteral Nutrition |
Competitive Landscape and Market Positioning
Key companies in the peripherally inserted central catheters market:
- Becton Dickinson and Company (United States)
- Teleflex Incorporated (United States)
- B. Braun Melsungen AG (Germany)
- ICU Medical, Inc. (United States)
- Cardinal Health, Inc. (United States)
- AngioDynamics, Inc. (United States)
- Terumo Corporation (Japan)
- Cook Medical LLC (United States)
- Medtronic plc (Ireland)
Clinical outcomes and procedural efficiency are increasingly defining how suppliers compete in the peripherally inserted central catheters market. Manufacturers are placing greater emphasis on catheter designs that simplify placement, reduce procedural complexity, and support infection prevention across a wide range of care settings. As healthcare providers seek standardized vascular access solutions with lower maintenance demands, competitive differentiation is expanding beyond product performance to include clinician support, compatibility with imaging and navigation technologies, and the ability to address diverse patient requirements through broader product portfolios.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (United States) | |||||||
| Teleflex Incorporated (United States) | |||||||
| B. Braun Melsungen AG (Germany) | |||||||
| ICU Medical Inc. (United States) | |||||||
| Cardinal Health Inc. (United States) | |||||||
| AngioDynamics Inc. (United States) | |||||||
| Terumo Corporation (Japan) | |||||||
| Cook Medical LLC (United States) | |||||||
| Medtronic plc (Ireland) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Teleflex Incorporated | Jul-25 | Teleflex completed the EUR 760 million acquisition of BIOTRONIK's vascular intervention business, expanding its catheter portfolio with vascular intervention technologies including drug-coated balloons and stents. The acquisition strengthens the company's interventional access and catheter franchise, enhancing its competitive position across the vascular access market. |
| BD | Feb-25 | BD announced plans to separate its Biosciences and Diagnostic Solutions business to sharpen its strategic focus on its core medical technology portfolio, including vascular access products such as peripherally inserted central catheters, supporting greater operational focus and long-term portfolio development. |
| Teleflex Incorporated | May-23 | Teleflex launched the Arrow VPS Rhythm DLX Device and NaviCurve Stylet in the United States to support peripherally inserted central catheter placement. The introduction expanded the company's vascular access portfolio by enhancing catheter navigation and placement capabilities, strengthening its offering for clinicians performing PICC procedures. |
| B. Braun Medical Inc. | Sep-22 | B. Braun Medical acquired the Clik-FIX catheter securement device portfolio from Starboard Medical, strengthening its vascular access product offering with enhanced catheter securement solutions. The acquisition expands the company's portfolio and reinforces its position in catheter management and associated clinical applications. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Peripherally Inserted Central Catheters Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Placement Approach | Ultrasound-Guided Placement, Landmark-Based Placement, ECG-Guided Placement |
| Dwell Duration | Short-Term, Intermediate-Term, Long-Term |
| Distribution Channel | Direct Sales, Medical Device Distributors, Group Purchasing Organizations |
Peripherally Inserted Central Catheters Market — report.custom
| Custom Chapter | Custom Details |
|---|---|
| Vascular Access Device Selection Patterns |
|
| Hospital Procurement and Contracting Dynamics |
|
| Home Infusion Adoption Outlook |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the peripherally inserted central catheters market generate?
How much is the peripherally inserted central catheters industry expected to grow by 2036?
How are long-term treatment needs driving adoption of peripherally inserted central catheters?
Why are technological advancements strengthening the peripherally inserted central catheters market?
Why do power injected PICCs lead the peripherally inserted central catheters market?
Why are homecare settings the fastest-growing end-use segment for peripherally inserted central catheters?
Why does North America lead the peripherally inserted central catheters market?
How is Asia Pacific accelerating PICC market growth?
What are the prominent companies operating in the peripherally inserted central catheters landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization